Who makes BIS-001, Treatment A?

BIS-001, Treatment A is developed by Supernus Pharmaceuticals, Inc..

What development phase is BIS-001, Treatment A in?

BIS-001, Treatment A is in Phase 1.

Last reviewed 2026-04-19 · How we verify

BIS-001, Treatment A

Supernus Pharmaceuticals, Inc. · Phase 1 active Small molecule

At a glance

Generic name	BIS-001, Treatment A
Also known as	Huperzine A
Sponsor	Supernus Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BIS-001, Treatment A CI brief — competitive landscape report
BIS-001, Treatment A updates RSS · CI watch RSS
Supernus Pharmaceuticals, Inc. portfolio CI